Rofleponide

Rofleponide

SCHEMBL5506220

CCCC1O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 9/20 0.68
▸ CYP3A4 P08684 4/20 0.51
▸ LMNA P02545 3/20 0.51
▸ HIF1A Q16665 3/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ PGR P06401 2/20 0.51
▸ AR P10275 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ ABCC3 O15438 1/20 0.49
▸ ABCC4 O15439 1/20 0.49
▸ ABCB11 O95342 1/20 0.49
▸ IL5 P05113 1/20 0.49
▸ NR3C2 P08235 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ MMP9 P14780 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ THPO P40225 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rofleponide SCHEMBL7196822 1.00 NR3C1 (0.68) NR3C1CYP3A4LMNAHIF1AHSD17B10
Rofleponide SCHEMBL74762 1.00 NR3C1 (0.68) NR3C1CYP3A4LMNAHIF1AHSD17B10
Rofleponide SCHEMBL23803954 1.00 NR3C1 (0.68) NR3C1CYP3A4LMNAHIF1AHSD17B10
Rofleponide SCHEMBL8505525 1.00 NR3C1 (0.68) NR3C1CYP3A4LMNAHIF1AHSD17B10
Rofleponide SCHEMBL6449744 0.97 NR3C1 (0.64) NR3C1CYP3A4LMNAHIF1AHSD17B10
SCHEMBL8204804 0.93 NR3C1 (0.67) NR3C1CYP3A4LMNAHIF1AHSD17B10
SCHEMBL7081817 0.93 NR3C1 (0.70) NR3C1CYP3A4LMNAHIF1AHSD17B10
SCHEMBL8674574 0.93 NR3C1 (0.70) NR3C1CYP3A4LMNAHIF1AHSD17B10
SCHEMBL6323559 0.92 NR3C1 (0.57) NR3C1CYP3A4LMNAHIF1AHSD17B10
SCHEMBL8138913 0.92 NR3C1 (0.66) NR3C1CYP3A4LMNAHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002088169-A2 PREPARATION OF GLUCOCORTICOSTEROIDS, 16, 17 ACETALS OR KETALS OF PREGNANE DERIVATIVES ASTRAZENECA AB (SE) 2002-11-07 — — WO claimed
US-5888995-A ANTIINFLAMMATORY AND ANTIALLERGENIC AGENTS; A NOVEL GLUCOCORTICOSTEROID ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US claimed
EP-1848444-A1 PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM GLAXO GROUP LIMITED (GB) 2007-10-31 — — EP disclosed
WO-2006086270-A1 PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM GLAXO GROUP LIMITED (GB) 2006-08-17 — — WO disclosed
US-20040019025-A1 Medical compositions comprising (r,r)-formoterol and rofleponide SMITHKLINE BEECHAM CORPORATION 2004-01-29 — — US disclosed
US-20030096874-A1 Respiratory compositions SMITHKLINE BEECHAM CORPORATION 2003-05-22 — — US disclosed
EP-1274434-A1 MEDICAL COMBINATIONS COMPRISING TIOTROPIUM AND ROFLEPONIDE GLAXO GROUP LIMITED (GB) 2003-01-15 — — EP disclosed
EP-1274441-A1 RESPIRATORY COMPOSITIONS GLAXO GROUP LIMITED (GB) 2003-01-15 — — EP disclosed
WO-2002088169-A2 PREPARATION OF GLUCOCORTICOSTEROIDS, 16, 17 ACETALS OR KETALS OF PREGNANE DERIVATIVES ASTRAZENECA AB (SE) 2002-11-07 — — WO disclosed
WO-2001078736-A1 MEDICAL COMBINATIONS COMPRISING TIOTROPIUM AND ROFLEPONIDE GLAXO GROUP LIMITED (GB) 2001-10-25 — — WO disclosed
WO-2001078746-A1 RESPIRATORY COMPOSITIONS GLAXO GROUP LIMITED (GB) 2001-10-25 — — WO disclosed
US-5939409-A CONDENSATION OF ALDEHYDE WITH STEROIDIOL TO FORM AN ACETAL GROUPS ASTRA AKTIEBOLAG (SE) 1999-08-17 — — US disclosed
EP-0678097-B1 NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES ASTRA AB (SE) 1999-08-11 — — EP disclosed
US-5908833-A GLUCOCORTICOSTEROID CHEMICALLY BOUND TO A SUGAR AKTIEBOLAGET ASTRA (SE) 1999-06-01 — — US disclosed
EP-0570454-B1 NOVEL STEROIDS ASTRA AB (SE) 1999-04-07 — — EP disclosed
US-5888995-A ANTIINFLAMMATORY AND ANTIALLERGENIC AGENTS; A NOVEL GLUCOCORTICOSTEROID ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US disclosed
EP-0572451-B1 NOVEL STEROID ESTERS ASTRA AB (SE) 1998-04-01 — — EP disclosed
US-5674861-A GLUCOCORTICOSTEROIDS FOR LOCAL TREATMENT OF INFLAMMATORY DISORDERS ASTRA AKTIEBOLAG (SE) 1997-10-07 — — US disclosed
US-5614514-A Steroid esters AKTIEBOLAGET ASTRA (SE) 1997-03-25 — — US disclosed
Send feedback